STOCK TITAN

RESEARCH SOLUTIONS INC - RSSS STOCK NEWS

Welcome to our dedicated page for RESEARCH SOLUTIONS news (Ticker: RSSS), a resource for investors and traders seeking the latest updates and insights on RESEARCH SOLUTIONS stock.

Research Solutions Inc. (NASDAQ: RSSS) is a pioneering force in providing cloud-based workflow solutions, designed to accelerate research for R&D-driven organizations. Established in 2006 as Reprints Desk, the company has significantly evolved to streamline the access, procurement, and legal use of scientific, technical, and medical (STM) research articles.

The company's core offering, the Article Galaxy platform, serves over 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses globally. This platform enables users to find and download digital versions of STM articles, manage transactions, automate authentication, and generate reports. It integrates seamlessly with corporate intranets, aiding organizations in speeding up their research and development activities.

Research Solutions has continually expanded its product suite through strategic acquisitions. In late July, the company acquired ResoluteAI, enhancing its artificial intelligence capabilities. More recently, in November 2023, the acquisition of scite added a revolutionary search and discovery platform that uses AI to increase the discoverability and evaluation of research.

Key achievements include being ranked #1 by Outsell Inc. in document delivery and winning numerous industry awards like the Association of Independent Information Professionals Technology Award and the KMWorld Magazine Trend-Setting Products award.

The company reported robust financial performance for its fiscal first quarter ended September 30, 2023, with total revenue reaching $10.1 million, a 16% increase from the previous year. The addition of ResoluteAI and scite significantly boosted the annual recurring revenue (ARR) to over $11 million. Despite inflationary pressures affecting growth in platform products, the focus on high-margin solutions and continual mergers and acquisitions are expected to sustain their growth trajectory.

Recent developments include the launch of the Technology Landscape Module and the Clinical Trial Landscape solution, both leveraging advanced AI to provide comprehensive analytics and insights, further cementing Research Solutions' position as a leader in scientific data integration.

As the company continues to innovate and expand its offerings, it remains dedicated to its mission of empowering researchers with the most effective tools and resources to drive innovation and achieve groundbreaking results.

For more detailed information, visit www.researchsolutions.com.

Rhea-AI Summary

Research Solutions, Inc. (NASDAQ: RSSS) will announce its financial results for the fiscal 2024 third quarter on May 9, 2024, following a conference call hosted by President and CEO Roy W. Olivier and CFO Bill Nurthen. The company specializes in cloud-based workflow solutions for R&D organizations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
-
Rhea-AI Summary
Research Solutions introduces AI-powered Clinical Trial Landscape software to enhance medical research with comprehensive data and analytics, aiming to streamline the clinical trial information discovery process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
-
Rhea-AI Summary
Research Solutions (RSSS) launches Technology Landscape Module, utilizing AI to produce reports in minutes, streamlining research processes for R&D-driven organizations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
AI
Rhea-AI Summary
Research Solutions, Inc. (NASDAQ: RSSS) reported a total revenue of $10.3 million, an 18.3% increase from the prior-year quarter. The Annual Recurring Revenue (ARR) reached $15.6 million, a 77% increase, with a net loss of $54,000. The company closed its acquisition of Scite, Inc. and experienced continued organic growth across its platform and transaction offerings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
-
Rhea-AI Summary
Research Solutions, Inc. (RSSS) will hold a conference call to discuss its financial results for the fiscal 2024 second quarter ended December 31, 2023, on Thursday, February 8, 2024, at 5:00 p.m. ET. The call will be hosted by President and CEO Roy W. Olivier and CFO Bill Nurthen. A press release containing the financial results will be issued following the market close and prior to the call. The call will be broadcast live and available for replay via the investor relations section of the company's website. A replay of the conference call will be available after 8:00 p.m. Eastern time on the same day through March 8, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
-
Rhea-AI Summary
Research Solutions, Inc. (NASDAQ: RSSS) announced that its President and CEO, Roy W. Olivier, and CFO, Bill Nurthen, will participate in the 2024 Healthcare IT Virtual Conference. The conference, hosted by Maxim Group LLC and M-Vest, will take place on January 24th at 3:30 pm ET. Investors can register to listen to the presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.72%
Tags
conferences
Rhea-AI Summary
Research Solutions, Inc. (RSSS) acquires scite, adding $3.6 million in annualized software subscription revenue. The acquisition enhances product offerings and provides cross-selling opportunities to a diverse customer base of approximately 21,000 active subscribers. scite's Smart Citations and AI-powered chatbot, scite Assistant, offer unique research features and fact-checking capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.71%
Tags
-
Rhea-AI Summary
Research Solutions, Inc. (NASDAQ: RSSS) announces participation in ROTH MKM 12th Annual Technology Conference and Southwest IDEAS Conference. The company will present at both events, offering insights into its cloud-based workflow solutions. Qualified investors can schedule a meeting with management for more information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
conferences
-
Rhea-AI Summary
Research Solutions, Inc. (NASDAQ: RSSS) reported a 16% increase in total revenue to $10.1 million for the fiscal first quarter ended September 30, 2023. The company's ARR surpassed $11.0 million, with platform revenue up 29% to $2.6 million. However, the loss of ($988,000) or ($0.04) per share was reported, compared to net income of $215,000 or $0.01 per diluted share in the prior-year quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
Rhea-AI Summary
Research Solutions, Inc. (NASDAQ: RSSS) will hold a conference call to discuss its financial results for the fiscal 2024 first quarter. The call will be hosted by President and CEO Roy W. Olivier and CFO Bill Nurthen.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags

FAQ

What is the current stock price of RESEARCH SOLUTIONS (RSSS)?

The current stock price of RESEARCH SOLUTIONS (RSSS) is $2.9 as of November 15, 2024.

What is the market cap of RESEARCH SOLUTIONS (RSSS)?

The market cap of RESEARCH SOLUTIONS (RSSS) is approximately 93.6M.

What does Research Solutions Inc. do?

Research Solutions Inc. provides cloud-based workflow solutions to streamline the access, management, and creation of intellectual property for R&D-driven organizations.

What is Article Galaxy?

Article Galaxy is Research Solutions' core SaaS research platform that enables users to find and download digital versions of scientific, technical, and medical articles.

What recent acquisitions has Research Solutions made?

In late July 2023, the company acquired ResoluteAI, and in November 2023, it acquired scite to enhance their AI capabilities and product offerings.

What are some key achievements of Research Solutions?

Research Solutions has been ranked #1 by Outsell Inc. for document delivery and has received numerous industry awards such as the AIIP Technology Award and KMWorld Magazine Trend-Setting Products award.

What financial performance did Research Solutions report recently?

For the fiscal first quarter ended September 30, 2023, the company reported total revenue of $10.1 million, a 16% increase from the previous year, and an ARR of over $11 million.

What new products have been launched by Research Solutions?

Recent launches include the Technology Landscape Module and the Clinical Trial Landscape solution, both utilizing advanced AI to provide comprehensive analytics and insights.

Who are the primary users of Research Solutions' platforms?

Over 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses globally rely on the company’s products.

How does Research Solutions support innovation?

Research Solutions supports innovation by offering comprehensive tools and resources that streamline the research process, enabling faster and more efficient access to critical scientific data.

Where can I find more information about Research Solutions?

For more detailed information, you can visit the company's official website at www.researchsolutions.com.

What is the significance of Research Solutions' recent acquisitions?

The acquisitions of ResoluteAI and scite have significantly enhanced Research Solutions' AI capabilities and expanded their product offerings, driving growth and innovation in the research community.

RESEARCH SOLUTIONS INC

Nasdaq:RSSS

RSSS Rankings

RSSS Stock Data

93.57M
32.55M
24%
40.54%
0.1%
Software - Application
Services-business Services, Nec
Link
United States of America
HENDERSON